Admission Date:  [**2154-3-3**]              Discharge Date:   [**2154-3-9**]  Date of Birth:  [**2075-11-14**]             Sex:   F  Service: MEDICINE  Allergies: Vicodin  Attending:[**First Name3 (LF) 2387**] Chief Complaint: Dyspnea and back/neck pain  Major Surgical or Invasive Procedure: None   History of Present Illness: 78 DM, PAD known severe AS [**Location (un) 109**] 0.9cm2 mean gradient of 20mmHg, CHF EF 35-40% with regional variation, 3vd cath 1mo ago, RLE angioplasty/stent for poorly healing TMA now presents with dyspnea and pain.
Her sats were recorded to be in the 70s.
She received lasix (20mg IV by report) with improvement in respiratory status, and was transferred to [**Hospital1 18**] for further management.
At the [**Hospital1 18**] ED, her presenting vitals were 99.9, 90/44 HR 113 RR 21 Sat 100% NRB.
Her BP dropped to 83/47 lowest recorded, and she received a 250cc saline bolus.
Neck: Supple with JVP of *10-12 cm.
CV: PMI located in 5th intercostal space, midclavicular line.
Neuro: Pulses: Right: Carotid 1+ Femoral 1+ Popliteal 0+ Left: Carotid 1+ Femoral 1+ Popliteal 0+  Pertinent Results: [**2154-3-3**] 08:15AM BLOOD WBC-9.0 RBC-2.97* Hgb-9.3* Hct-27.9* MCV-94 MCH-31.4 MCHC-33.4 RDW-15.5 Plt Ct-297 [**2154-3-7**] 06:55AM BLOOD WBC-8.4 RBC-2.87* Hgb-9.1* Hct-26.3* MCV-91 MCH-31.6 MCHC-34.6 RDW-15.3 Plt Ct-391 [**2154-3-3**] 08:15AM BLOOD Glucose-208* UreaN-15 Creat-0.8 Na-136 K-4.4 Cl-101 HCO3-28 AnGap-11 [**2154-3-7**] 06:55AM BLOOD Glucose-113* UreaN-35* Creat-0.7 Na-139 K-4.0 Cl-99 HCO3-31 AnGap-13 [**2154-3-3**] 08:15AM BLOOD cTropnT-0.05* [**2154-3-3**] 08:15AM BLOOD CK-MB-NotDone cTropnT-0.06* proBNP-5950* [**2154-3-3**] 04:33PM BLOOD CK-MB-NotDone cTropnT-0.10* [**2154-3-3**] 08:15AM BLOOD ALT-14 AST-16 CK(CPK)-39 AlkPhos-40 TotBili-0.5 [**2154-3-3**] 08:15AM BLOOD Lipase-27 [**2154-3-4**] 01:41AM BLOOD TSH-2.5 [**2154-3-5**] 11:39AM BLOOD %HbA1c-5.8  Urine cx ([**3-3**]): negative Blood cx ([**3-3**] x2, [**3-5**] x2): NGTD  CXR ([**3-3**]): Interval development of pulmonary edema; repeat PA and lateral when clinically feasible may be beneficial.
TTE ([**3-4**]): The left atrium is elongated.
Compared with the prior study (images reviewed) of [**2154-1-28**], global left ventricular systolic function is more depressed (and apprears global) and the severity of aortic stenosis has progressed.
CXR ([**3-5**]): In comparison with the study of [**3-3**], the hemidiaphragms are more sharply seen.
TTE showed global LV systolic dysfunction and severe aortic stenosis.
Her outpatient furosemide was increased from 20mg once a day to 40mg once a day.
Metoprolol was increased from 12.5mg twice daily to 37.5mg three times a day but her blood pressure could not tolerate and she was weaned back to metoprolol 12.5mg PO BId.
Also, her blood pressure has not tolerated past attempts to control her heart rate with medications.
4) Fevers: CXR did not suggest pneumonia, urine culture was negative, and blood cultures were negative to date at discharge.
Her fever curve trended down and she had no leukocytosis.
Peripheral [**Hospital1 **] Disease 3.
You should continue to follow-up with your outpatient cardiologist, [**Hospital1 1106**] surgeon, and cardiothoracic surgery team when you are discharged.
Weigh yourself every morning, [**Name8 (MD) 138**] MD if weight > 3 lbs in 1 day or 6 poounds in 3 days.
Adhere to 2 gm sodium diet Fluid Restriction: 1.5 liters a day or about 6 cups per day  Followup Instructions: Please follow-up with your surgeon and the [**Name8 (MD) 1106**] lab at your previously scheduled appointments: - Provider: [**Name10 (NameIs) **] LAB Phone:[**Telephone/Fax (1) 1237**] Date/Time:[**2154-3-15**] 1:00 - Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 1244**], MD Phone:[**Telephone/Fax (1) 1237**] Date/Time:[**2154-3-15**] 1:45 .
